{{Rsnum
|rsid=2940944
|Gene=GHR
|Chromosome=5
|position=42489040
|Orientation=minus
|GMAF=0.4141
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=GHR
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 24.8 | 48.7 | 26.5
| HCB | 0.7 | 23.4 | 75.9
| JPT | 0.0 | 14.2 | 85.8
| YRI | 24.5 | 51.7 | 23.8
| ASW | 29.8 | 50.9 | 19.3
| CHB | 0.7 | 23.4 | 75.9
| CHD | 2.8 | 24.8 | 72.5
| GIH | 7.9 | 42.6 | 49.5
| LWK | 31.8 | 47.3 | 20.9
| MEX | 13.8 | 53.4 | 32.8
| MKK | 25.0 | 56.4 | 18.6
| TSI | 21.6 | 60.8 | 17.6
| HapMapRevision=28
}}{{PMID Auto
|PMID=19487270
|Title=A study of relationships between single nucleotide polymorphisms from the growth hormone-insulin-like growth factor axis and bone mass: the Hertfordshire cohort study
}}

{{PMID Auto
|PMID=20445798
|Title=Chromosome 5p Region SNPs Are Associated with Risk of NSCLC among Women.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}